JANX December 2026 Options Begin Trading

The article outlines options strategies for Janux Therapeutics (JANX), currently trading at $26.85, highlighting opportunities for income generation or discounted share acquisition. Selling a $25.00 strike put for $5.00 offers an effective purchase price of $20.00 and a potential 20% YieldBoost if the contract expires worthless, with a 73% probability. Alternatively, a covered call strategy utilizing a $35.00 strike call for $5.60 could generate a 51.21% return by December 2026 if shares are called away, or an 18.75% annualized YieldBoost if the call expires worthless (40% probability), leveraging the stock's elevated implied volatility of 86-88% compared to its 75% historical volatility.

Analysis

The article highlights two distinct options strategies for Janux Therapeutics (JANX), currently trading at $26.85, designed for either discounted share acquisition or enhanced income generation. Selling a $25.00 strike put for a $5.00 premium offers an effective purchase price of $20.00, representing a 25.5% discount to the current market price. This out-of-the-money put carries a 73% probability of expiring worthless, which would yield a 20.00% return on the cash commitment, or 17.98% annualized.

Alternatively, a covered call strategy involves purchasing JANX shares at $26.85 and simultaneously selling a $35.00 strike call for $5.60. This approach could generate a 51.21% total return by December 2026 if the shares are called away, or an 18.75% annualized YieldBoost if the call expires worthless, an event with a 40% probability. The $35.00 strike is approximately 30% out-of-the-money, indicating a significant upside buffer.

Both strategies capitalize on JANX's elevated implied volatility, with the put contract at 88% and the call contract at 86%. This is notably higher than the stock's trailing twelve-month historical volatility of 75%, suggesting that options premiums are currently enriched. This premium offers an attractive opportunity for option sellers to generate income or achieve favorable entry points.

Key Decisions for Investors

• Investors interested in acquiring JANX shares at a discount should consider selling the $25.00 strike put, leveraging the 73% probability of the option expiring worthless to achieve an effective $20.00 entry price and a 20% premium return.
• For existing or new JANX shareholders, evaluating a covered call strategy using the $35.00 strike call can generate substantial income, offering up to a 51.21% total return if shares are called away, while accepting a cap on upside participation beyond the strike price.